Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy
Clinical trial NCT04130152 · COMPLETED
Trial details
- NCT number
- NCT04130152
- Sponsor
- SOLTI Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2022-01-26
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.